Endothelial Disfunction Treatment With Glimepiride/Metformin Combination (Glimetal) in Type 2 Diabetes Patients

• Status: Completed
• Trial end date: 2008-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The Purpose of this study was to evaluate the effect of the combination glimepiride/metformin over endothelial dysfunction (ED) in asymptomatic patients with type 2 diabetes mellitus (DM) using 13N-ammonia-positron emission tomography (PET).

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Laboratorios Silanes S.A. de C.V.
• Treatments: Glimepiride; Metformin

Criteria

Inclusion Criteria:

• Both genders

• At least 18 years old

• Type 2 diabetes mellitus diagnosis

• Signed Informed Consent

Exclusion Criteria:

• History of smoking, hypertension, dyslipidemia, ischemic heart disease or autoimmune rheumatic diseases

• Pregnancy or lactation

• History of abuse and/or substance dependence within 6 months preceding the survey.

• History of glimepiride or metformin allergy